Oric Pharmaceuticals, Inc. (ORIC) Operating cash flow 2018–2025
Oric Pharmaceuticals, Inc. (ORIC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$111.0MFY2025 · since FY2018: -$20.7M → -$111.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$111.0M | +1.5% |
| FY2024 | -$112.7M | -31.5% |
| FY2023 | -$85.7M | -14.0% |
| FY2022 | -$75.1M | -26.2% |
| FY2021 | -$59.5M | -31.5% |
| FY2020 | -$45.3M | -92.4% |
| FY2019 | -$23.5M | -13.8% |
| FY2018 | -$20.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice